Related Experiment Video
Updated: Feb 14, 2026

In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
Published on: April 18, 2019
Application and impact of run-in studies
Michael Fralick1,2,3, Jerry Avorn4,5, Jessica M Franklin4,5
1Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Ste 3030, Boston, MA, 02120, USA. mif823@mail.harvard.edu.
Run-in phases in clinical trials do not significantly alter medication efficacy or safety outcomes. These lengthy phases may not be necessary, questioning their utility and cost-effectiveness in research.
Area of Science:
- Clinical Trials Methodology
- Pharmacology
- Evidence-Based Medicine
Background:
- Run-in phases are common in clinical trials to screen participants.
- These phases can exclude patients, potentially affecting generalizability.
- Concerns exist regarding the necessity and impact of run-in periods.
Purpose of the Study:
- To compare clinical outcomes in randomized controlled trials (RCTs) with and without run-in phases.
- To assess the impact of run-in phases on medication efficacy and safety.
- To evaluate the utility of run-in phases in DPP-4 inhibitor trials.
Main Methods:
- Systematic review and meta-analysis of published RCTs for four DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin, alogliptin).
- Data extraction included hemoglobin A1C reduction and serious adverse events.
- Pooled results using random effects meta-analysis.
Main Results:
- 106 trials were identified; 88 included run-in phases (average 4.0 weeks).
- No significant differences in hemoglobin A1C reduction between trials with and without run-in phases.
- Similar proportions of serious adverse events were observed in both trial types.
Conclusions:
- Run-in phases did not significantly alter efficacy or safety findings in DPP-4 inhibitor trials.
- The cost and time associated with run-in phases may outweigh their benefits.
- The utility of run-in phases in short-duration clinical trials warrants reconsideration.
Related Concept Videos
Impact of Groups on Groups
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
Impact of Groups on Individuals
Impact of Individuals on a Group
Impact of Schemas
Types of Impact
The coefficient of restitution is a metric for understanding the dynamics of impacts. It quantifies the ratio of relative velocity...

